Dodge & Cox — REGN Trade History
Quarter-by-quarter changes in the Regeneron Pharmaceuticals, Inc. position · CUSIP 75886F107
Currently held · 4.8 YearsFirst seen: 2021 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Add | 4,871,137 | 412,899 | +9.3% | $3.04B | 1.59% |
| 2026 Q1 | 2026-05-14 | Reduce | 4,458,238 | -138,120 | -3.0% | $3.44B | 1.89% |
| 2025 Q4 | 2026-02-13 | Add | 4,596,358 | 45,513 | +1.0% | $3.55B | 1.92% |
| 2025 Q3 | 2025-11-13 | Add | 4,550,845 | 724,562 | +18.9% | $2.56B | 1.38% |
| 2025 Q2 | 2025-08-13 | Add | 3,826,283 | 1,502,198 | +64.6% | $2.01B | 1.13% |
| 2025 Q1 | 2025-05-14 | Add | 2,324,085 | 2,769 | +0.1% | $1.47B | 0.84% |
| 2024 Q4 | 2025-02-13 | Add | 2,321,316 | 9,381 | +0.4% | $1.65B | 0.96% |
| 2024 Q3 | 2024-11-13 | Reduce | 2,311,935 | -3,751 | -0.2% | $2.43B | 1.37% |
| 2024 Q2 | 2024-08-13 | Reduce | 2,315,686 | -44,178 | -1.9% | $2.43B | 1.46% |
| 2024 Q1 | 2024-05-14 | Reduce | 2,359,864 | -7,816 | -0.3% | $2.27B | 1.32% |
| 2023 Q4 | 2024-02-22 | Reduce | 2,367,680 | -5,318 | -0.2% | $2.08B | 1.32% |
| 2023 Q3 | 2023-11-14 | Reduce | 2,372,998 | -21,357 | -0.9% | $1.95B | 1.32% |
| 2023 Q2 | 2023-08-14 | Add | 2,394,355 | 9,654 | +0.4% | $1.72B | 1.15% |
| 2023 Q1 | 2023-05-12 | Add | 2,384,701 | 161,642 | +7.3% | $1.96B | 1.33% |
| 2022 Q4 | 2023-02-14 | Reduce | 2,223,059 | -63,450 | -2.8% | $1.60B | 1.10% |
| 2022 Q3 | 2022-11-10 | Add | 2,286,509 | 21,175 | +0.9% | $1.58B | 1.19% |
| 2022 Q2 | 2022-08-12 | Add | 2,265,334 | 28,271 | +1.3% | $1.34B | 0.93% |
| 2022 Q1 | 2022-05-13 | Add | 2,237,063 | 1,957,941 | +701.5% | $1.56B | 0.95% |
| 2021 Q4 | 2022-02-14 | New | 279,122 | 279,122 | — | $176.3M | 0.11% |
| 2021 Q3 | 2021-11-15 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-13 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-14 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-11 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-13 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-21 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-14 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-11 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-12 | — | — | — | — | — | — |
| 2016 Q4 | 2017-03-20 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.